State-of-the-Art of Neurogenic Bladder Disease

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Urology & Nephrology".

Deadline for manuscript submissions: closed (15 September 2023) | Viewed by 2461

Special Issue Editors


E-Mail Website
Guest Editor
Department of Urology, Faculty of Medicine, Comenius University in Bratislava, Limbova 5, 833 05 Bratislava, Slovakia
Interests: urology; bladder cancer; urethra, tissue engineering

E-Mail Website
Guest Editor
Department of Urology, Faculty of Medicine, Comenius University, Limbova 5, 833 05 Bratislava, Slovakia
Interests: urology; oncology; transplantation
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Comenius University Medical School, Bratislava, Slovakia
Interests: medical biology; tissue engineering; genetics and clinical genetics

Special Issue Information

Dear Colleagues,

Neurogenic bladder disease denotes dysfunction of the lower urinary tract caused by a neurologic disorder. Etiology varies from severe (spinal cord injury, sclerosis multiplex, etc.), to idiopathic impairment, it represents a complex of causes that require different (often individual) approaches and treatments. It poses a significant socioeconomic burden for healthcare and dramatically lowers patients’ quality of life. Due to its complex nature, diagnosis, treatment, and research require multi-disciplinary involvement. In recent years, significant progress has been made in the treatment and research of this disease, and some experimental treatments hold promise for the near future.

The purpose of this Special Issue is to encourage researchers to share their latest research and to summarize the recent advances in clinical and pathologic aspects of neurogenic bladder disease. We invite authors to submit original articles and review articles focusing on pertinent topics and new advances in neurogenic bladder disease.

Dr. Stanislav Źiaran
Prof. Dr. Peter Bujdák
Prof. Dr. Lubos Danisovic
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurogenic
  • bladder
  • disease
  • lower urinary tract dysfunction

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 537 KiB  
Review
Tissue Engineering and Stem Cell Therapy in Neurogenic Bladder Dysfunction: Current and Future Perspectives
by Katarina Topoliova, Stefan Harsanyi, Lubos Danisovic and Stanislav Ziaran
Medicina 2023, 59(8), 1416; https://doi.org/10.3390/medicina59081416 - 3 Aug 2023
Cited by 2 | Viewed by 2194
Abstract
Tissue engineering (TE) is a rapidly evolving biomedical discipline that can play an important role in treating neurogenic bladder dysfunction and compensating for current conventional options’ shortcomings. This review aims to analyze the current status of preclinical and clinical trials and discuss what [...] Read more.
Tissue engineering (TE) is a rapidly evolving biomedical discipline that can play an important role in treating neurogenic bladder dysfunction and compensating for current conventional options’ shortcomings. This review aims to analyze the current status of preclinical and clinical trials and discuss what could be expected in the future based on the current state of the art. Although most preclinical studies provide promising results on the effectiveness of TE and stem cell therapies, the main limitations are mainly the very slow translation of preclinical trials to clinical trials, lack of quality research on neurogenic preconditions of neurogenic bladder dysfunction outside of the spinal cord injury and varying therapeutic methods of the existing research that lacks a standardized approach. Full article
(This article belongs to the Special Issue State-of-the-Art of Neurogenic Bladder Disease)
Show Figures

Figure 1

Back to TopTop